Webcast
11:30 - 12:30
EST

New frontiers and emerging treatments for CLL

Join Dr.Versha Banerji, a Canadian leader in CLL treatment and research, who will provide the latest in the diagnosis and treatment of the disease.
Dr. Banerji will speak about:

  • Who the disease affects and how it progresses
  • How decisions are made about when to treat and the factors that influence the choice of treatment
  • Promising new treatments being studied in clinical trials
  • What the future holds

Virtual Event

Virtual Event
Virtual Event

Agenda

11:30 - 12:30
New frontiers and emerging treatments for CLL

Speaker

Dr. Versha Banerji
Dr. Versha Banerji
MD FRCPC
Dr. Versha Banerji MD FRCPC obtained her MD and residency training in Internal Medicine and Hematology at the University of Manitoba. She then completed a post-doctoral fellowship in translational research at the Harvard Cancer Centre/ Dana-Farber Cancer Institute and Broad Institute of MIT. She is a Senior Scientist at the CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba.

She Co-leads the CLL clinic and is involved in several clinical trials and population-based treatment studies. As Co-chair of the CLL Research Program she manages a multi-disciplinary research team in clinical, fundamental, and translational research. Her own laboratory is evaluating mitochondrial bioenergetics and function as a measure of cancer cell metabolism.